Back
BSX logo

Boston Scientific Corp (BSX)

Health Care
BSX · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →
$42.74
+1.69%

Weekly undervalued picks (like BSX)

Price · 1 year
Loading live analysis…
Loading analysis…

Intrinsic Investor is for research and education only. Not financial advice.

Key metrics

EPS
$1.94
ROE
14.7%
Gross margin
68.9%
Debt/Equity
0.42x
Revenue growth
11.6%

Boston Scientific Corp — company intelligence

Earnings surprises

Q2 2026$0.86 vs $0.84 est+2.9%
Q1 2026$0.80 vs $0.79 est+0.7%
Q4 2025$0.80 vs $0.79 est+1.6%
Q3 2025$0.75 vs $0.72 est+4.1%

Analyst consensus · 38 analysts

30 Buy8 Hold0 Sell
Updated Oct 9, 2026

Insider activity · 90 days

10 buys1 sellnet +295,150 shares
O'Connor Padraig Andrewother 1,171 · Sep 2, 2026
O'Connor Padraig AndrewSell 567 · Sep 2, 2026
Morano Susan EBuy 2,040 · Aug 25, 2026

AI Valuation Narrative

Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.

Weekly undervalued picks (like BSX)

Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.

Free. No spam. We only email once per week.

Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.